Reuters: GTx prostate-cancer drug reduces hot flashes in men

[staff]

GTx prostate-cancer drug reduces hot flashes in men
      

(Reuters) - Biotechnology company GTx Inc said a late-stage trial showed its experimental drug, toremifene citrate, reduced hot flashes in men who were on Androgen deprivation therapy (ADT), a common treatment for advanced prostate cancer.
<p>You are not allowed to view links. Register or Login</p><div class="feedflare">
You are not allowed to view links. Register or Login You are not allowed to view links. Register or Login You are not allowed to view links. Register or Login
</div><img src="You are not allowed to view links. Register or Login" height="1" width="1"/>
      

You are not allowed to view links. Register or Login